| Novel immunotherapies for adult patients with B-lineage acute lymphoblastic leukemia G Wei, J Wang, H Huang, Y Zhao Journal of Hematology & Oncology 10, 1-13, 2017 | 108 | 2017 |
| Role of fluorodeoxyglucose positron emission tomography/computed tomography in predicting the adverse effects of chimeric antigen receptor T cell therapy in patients with non … J Wang, Y Hu, S Yang, G Wei, X Zhao, W Wu, Y Zhang, Y Zhang, D Chen, ... Biology of Blood and Marrow Transplantation 25 (6), 1092-1098, 2019 | 87 | 2019 |
| Advances of CD19-directed chimeric antigen receptor-modified T cells in refractory/relapsed acute lymphoblastic leukemia G Wei, L Ding, J Wang, Y Hu, H Huang Experimental Hematology & Oncology 6, 1-7, 2017 | 84 | 2017 |
| Acute lymphoblastic leukemia relapse after CD19-targeted chimeric antigen receptor T cell therapy J Wang, Y Hu, H Huang Journal of leukocyte biology 102 (6), 1347-1356, 2017 | 52 | 2017 |
| A retrospective comparison of allogenic and autologous chimeric antigen receptor T cell therapy targeting CD19 in patients with relapsed/refractory acute lymphoblastic leukemia Y Hu, J Wang, G Wei, J Yu, Y Luo, J Shi, W Wu, K Zhao, L Xiao, Y Zhang, ... Bone Marrow Transplantation 54 (8), 1208-1217, 2019 | 49 | 2019 |
| Risk and prognostic factors of transplantation‐associated thrombotic microangiopathy in allogeneic haematopoietic stem cell transplantation: a nested case control study Y Ye, W Zheng, J Wang, Y Hu, Y Luo, Y Tan, J Shi, M Zhang, H Huang Hematological Oncology 35 (4), 821-827, 2017 | 45 | 2017 |
| Current development of chimeric antigen receptor T-cell therapy J Wang, Y Hu, H Huang Stem Cell Investigation 5, 2018 | 35 | 2018 |
| Differential risk of cancer associated with glucagon-like peptide-1 receptor agonists: analysis of real-world databases J Wang, CH Kim Endocrine Research 47 (1), 18-25, 2022 | 27 | 2022 |
| Incidence and risk of various types of arterial thromboembolism in patients with cancer J Wang, YD Kim, CH Kim Mayo clinic proceedings 96 (3), 592-600, 2021 | 23 | 2021 |
| The many faces of cytokine release syndrome-related coagulopathy J Wang, J Doran Clinical Hematology International 3 (1), 3-12, 2021 | 23 | 2021 |
| Development of pancytopenia in a patient with COVID‐19. Y Zhao, J He, J Wang, WM Li, M Xu, X Yu, W Wu, C Sun, Z Xu, W Zhang, ... Journal of Medical Virology 93 (3), 2021 | 22 | 2021 |
| Salvage therapy with dose-escalating ruxolitinib as a bridge to allogeneic stem cell transplantation for refractory hemophagocytic lymphohistiocytosis Y Zhao, J Shi, X Li, J Wang, J Sun, J Zhou, H Huang Bone Marrow Transplantation 55 (4), 824-826, 2020 | 18 | 2020 |
| Delayed terminal ileal perforation in a relapsed/refractory B-cell lymphoma patient with rapid remission following chimeric antigen receptor T-cell therapy Y Hu, J Wang, C Pu, K Zhao, Q Cui, G Wei, W Wu, L Xiao, Y Xiao, J Wang, ... Cancer Research and Treatment: Official Journal of Korean Cancer Association …, 2018 | 14 | 2018 |
| Venous thromboembolism in patients with multiple myeloma receiving daratumumab-based regimens: a post hoc analysis of phase 3 clinical trials J Wang, C Park, R Arroyo-Suarez Leukemia & Lymphoma 62 (9), 2219-2226, 2021 | 13 | 2021 |
| Diagnostic accuracy of the proton pump inhibitor test in gastroesophageal reflux disease and noncardiac chest pain: a systematic review and meta-analysis S Ghoneim, J Wang, NEH Chehade, SJ Ganocy, E Chitsaz, R Fass Journal of Clinical Gastroenterology 57 (4), 380-388, 2023 | 12 | 2023 |
| Risk of thromboembolism in patients with multiple myeloma treated with daratumumab: a systemic review and meta-analysis J Wang, Y Kim International Journal of Hematology 112 (5), 650-657, 2020 | 12 | 2020 |
| Umbilical cord blood derived cellular therapy: advances in clinical development J Wang, L Metheny Frontiers in Oncology 13, 1167266, 2023 | 10 | 2023 |
| No association between chronic use of ranitidine, compared with omeprazole or famotidine, and gastrointestinal malignancies YD Kim, J Wang, F Shibli, KE Poels, SJ Ganocy, R Fass Alimentary Pharmacology & Therapeutics 54 (5), 606-615, 2021 | 9 | 2021 |
| Update on small molecule targeted therapies for acute myeloid leukemia J Wang, B Tomlinson, HM Lazarus Current Treatment Options in Oncology 24 (7), 770-801, 2023 | 8 | 2023 |
| Malignancies associated with DPP4 inhibitors and GLP1 receptor agonists: Data from a large real-world database. J Wang, CH Kim Journal of Clinical Oncology 38 (15_suppl), 1567-1567, 2020 | 8 | 2020 |
